{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:41:53Z","timestamp":1784716913211,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011017","name":"Recherches Scientifiques Luxembourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["370C-20250066"],"award-info":[{"award-number":["370C-20250066"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119652","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:14:20Z","timestamp":1781302460000},"page":"119652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Selective HDAC6 inhibition perturbs autophagy and enhances integrated stress response-mediated immunogenic apoptosis in chronic myeloid leukemia"],"prefix":"10.1016","volume":"201","author":[{"given":"Ji Yeon","family":"Paik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi Reddy","family":"Gajulapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Orlikova-Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5918-923X","authenticated-orcid":false,"given":"Anne","family":"Lorant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christo","family":"Christov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0550-9538","authenticated-orcid":false,"given":"Michael","family":"Schnekenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9308-8176","authenticated-orcid":false,"given":"Claudia","family":"Cerella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0115-4725","authenticated-orcid":false,"given":"Marc","family":"Diederich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2026.119652_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.25792","article-title":"Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring","volume":"95","author":"Jabbour","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119652_bib2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood.2023022538","article-title":"BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib","volume":"144","author":"Leyte-Vidal","year":"2024","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.biopha.2026.119652_bib3","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/s41375-024-02314-7","article-title":"The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib","volume":"38","author":"Leske","year":"2024","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.biopha.2026.119652_bib4","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1038\/leu.2017.264","article-title":"Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib","volume":"31","author":"Qiang","year":"2017","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.biopha.2026.119652_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41375-018-0252-4","article-title":"Targeting quiescent leukemic stem cells using second generation autophagy inhibitors","volume":"33","author":"Baquero","year":"2019","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.biopha.2026.119652_bib6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2174\/15680096113139990088","article-title":"Autophagy in chronic myeloid leukaemia: stem cell survival and implication in therapy","volume":"13","author":"Helgason","year":"2013","journal-title":"Curr. Cancer Drug. Targets"},{"issue":"3","key":"10.1016\/j.biopha.2026.119652_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2015.01.002","article-title":"UPR, autophagy, and mitochondria crosstalk underlies the ER stress response","volume":"40","author":"Senft","year":"2015","journal-title":"Trends Biochem. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119652_bib8","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1002\/jcp.26137","article-title":"Crosstalk of ER stress-mediated autophagy and ER-phagy: involvement of UPR and the core autophagy machinery","volume":"233","author":"Song","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119652_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084368","article-title":"Mechanism of decision making between autophagy and apoptosis induction upon endoplasmic reticulum stress","volume":"25","author":"Kapuy","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119652_bib10","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/emboj.2011.497","article-title":"A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death","volume":"31","author":"Garg","year":"2012","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.biopha.2026.119652_bib11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/emboj.2009.1","article-title":"Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death","volume":"28","author":"Panaretakis","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2026.119652_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semcancer.2015.02.004","article-title":"eIF2alpha phosphorylation as a biomarker of immunogenic cell death","volume":"33","author":"Kepp","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119652_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"issue":"6062","key":"10.1016\/j.biopha.2026.119652_bib14","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.1208347","article-title":"Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice","volume":"334","author":"Michaud","year":"2011","journal-title":"Science"},{"issue":"7317","key":"10.1016\/j.biopha.2026.119652_bib15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nature09413","article-title":"Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis","volume":"467","author":"Chekeni","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2026.119652_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/cdd.2013.75","article-title":"Molecular mechanisms of ATP secretion during immunogenic cell death","volume":"21","author":"Martins","year":"2014","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.biopha.2026.119652_bib17","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fimmu.2018.01310","article-title":"Myeloid-derived suppressor cells hinder the anti-cancer activity of immune checkpoint inhibitors","volume":"9","author":"Weber","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119652_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119652_bib19","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/MCB.26.8.3071-3084.2006","article-title":"Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression","volume":"26","author":"Hu","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119652_bib20","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/cdd.2016.5","article-title":"Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation","volume":"23","author":"Garg","year":"2016","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.biopha.2026.119652_bib21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/cac2.12590","article-title":"Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy","volume":"44","author":"Schnekenburger","year":"2024","journal-title":"Cancer Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119652_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40364-024-00594-w","article-title":"Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation","volume":"12","author":"Orlikova-Boyer","year":"2024","journal-title":"Biomark. Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119652_bib23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/cancers12020318","article-title":"HDAC6-an emerging target against chronic myeloid leukemia?","volume":"12","author":"Losson","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2026.119652_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-024-01551-8","article-title":"Advances in targeting histone deacetylase for treatment of solid tumors","volume":"17","author":"Shi","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119652_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2013.09.026","article-title":"Antiproliferative and proapoptotic activities of 4-hydroxybenzoic acid-based inhibitors of histone deacetylases","volume":"343","author":"Seidel","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119652_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105058","article-title":"The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia","volume":"160","author":"Losson","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119652_bib27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.leu.2404549","article-title":"Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase","volume":"21","author":"Diaz-Blanco","year":"2007","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.biopha.2026.119652_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/FPC.0b013e328351f3e9","article-title":"Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression","volume":"22","author":"Benito","year":"2012","journal-title":"Pharm. Genom."},{"issue":"12","key":"10.1016\/j.biopha.2026.119652_bib29","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1002\/cam4.1187","article-title":"Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib","volume":"6","author":"Aviles-Vazquez","year":"2017","journal-title":"Cancer Med."},{"issue":"7607","key":"10.1016\/j.biopha.2026.119652_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Abraham","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2026.119652_bib31","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2141.2008.07261.x","article-title":"An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase","volume":"142","author":"Kohlmann","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"7757","key":"10.1016\/j.biopha.2026.119652_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2026.119652_bib33","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/15548627.2016.1162359","article-title":"ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells","volume":"12","author":"Karvela","year":"2016","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.biopha.2026.119652_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/joah.joah_176_20","article-title":"Scattergram patterns of hematological malignancies on sysmex XN-series analyzer","volume":"12","author":"Ningombam","year":"2021","journal-title":"J. Appl. Hematol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119652_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.biopha.2026.119652_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194820","article-title":"Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia-from molecular mechanisms to clinical relevance","volume":"13","author":"Alves","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2026.119652_bib37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-023-01469-6","article-title":"Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management","volume":"8","author":"Shyam Sunder","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119652_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.643382","article-title":"Combination therapies in chronic myeloid leukemia for potential treatment-free remission: focus on leukemia stem cells and immune modulation","volume":"11","author":"Mu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119652_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"issue":"Pt C","key":"10.1016\/j.biopha.2026.119652_bib40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.semcdb.2022.09.009","article-title":"Immunomodulatory properties of HDAC6 inhibitors in cancer diseases: new chances for sophisticated drug design and treatment optimization","volume":"154","author":"Biersack","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119652_bib41","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S1470-2045(16)30375-8","article-title":"Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial","volume":"17","author":"Yee","year":"2016","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119652_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26031274","article-title":"Regulation of HDAC6 catalytic activity in cancer: the role of post-translational modifications and protein-protein interactions","volume":"26","author":"Asaad","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"57","key":"10.1016\/j.biopha.2026.119652_bib43","doi-asserted-by":"crossref","first-page":"96984","DOI":"10.18632\/oncotarget.18904","article-title":"Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence","volume":"8","author":"Ianniciello","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biopha.2026.119652_bib44","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Bellodi","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.biopha.2026.119652_bib45","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s13287-021-02659-1","article-title":"Chronic myeloid leukemia stem cells: targeting therapeutic implications","volume":"12","author":"Mojtahedi","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"24","key":"10.1016\/j.biopha.2026.119652_bib46","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1182\/blood.2021014689","article-title":"Asciminib: a new therapeutic option in chronic-phase CML with treatment failure","volume":"139","author":"Yeung","year":"2022","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.biopha.2026.119652_bib47","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa1902328","article-title":"Asciminib in chronic myeloid leukemia after ABL kinase inhibitor failure","volume":"381","author":"Hughes","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.biopha.2026.119652_bib48","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/1535-7163.MCT-08-0186","article-title":"Caspase-2 functions upstream of mitochondria in endoplasmic reticulum stress-induced apoptosis by bortezomib in human myeloma cells","volume":"7","author":"Gu","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"12","key":"10.1016\/j.biopha.2026.119652_bib49","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1128\/MCB.00013-08","article-title":"Caspase-2 cleavage of BID is a critical apoptotic signal downstream of endoplasmic reticulum stress","volume":"28","author":"Upton","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119652_bib50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","article-title":"The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress","volume":"115","author":"Kawaguchi","year":"2003","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.biopha.2026.119652_bib51","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1101\/gad.436407","article-title":"HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates","volume":"21","author":"Boyault","year":"2007","journal-title":"Genes. Dev."},{"issue":"14","key":"10.1016\/j.biopha.2026.119652_bib52","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/sj.emboj.7601210","article-title":"HDAC6-p97\/VCP controlled polyubiquitin chain turnover","volume":"25","author":"Boyault","year":"2006","journal-title":"EMBO J."},{"issue":"16","key":"10.1016\/j.biopha.2026.119652_bib53","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1093\/nar\/gkt563","article-title":"The eIF2alpha\/ATF4 pathway is essential for stress-induced autophagy gene expression","volume":"41","author":"B'Chir","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"21","key":"10.1016\/j.biopha.2026.119652_bib54","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.4161\/cc.22387","article-title":"The PERK-eIF2alpha phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells","volume":"11","author":"Kusio-Kobialka","year":"2012","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.biopha.2026.119652_bib55","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.celrep.2018.10.021","article-title":"Integrated stress response activity marks stem cells in normal hematopoiesis and leukemia","volume":"25","author":"van Galen","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119652_bib56","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1186\/s12885-023-11623-6","article-title":"Synergistic lethality in chronic myeloid leukemia \u2013 targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment","volume":"23","author":"Haselbarth","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119652_bib57","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jare.2024.10.003","article-title":"Integrated stress response activation induced by usnic acid alleviates BCL-2 inhibitor ABT-199 resistance in acute myeloid leukemia","volume":"74","author":"Wu","year":"2025","journal-title":"J. Adv. Res."},{"issue":"415","key":"10.1016\/j.biopha.2026.119652_bib58","doi-asserted-by":"crossref","first-page":"ra17","DOI":"10.1126\/scisignal.aac4380","article-title":"ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies","volume":"9","author":"Ishizawa","year":"2016","journal-title":"Sci. Signal."},{"issue":"6887","key":"10.1016\/j.biopha.2026.119652_bib59","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2026.119652_bib60","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/emboj.2009.405","article-title":"HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy","volume":"29","author":"Lee","year":"2010","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.biopha.2026.119652_bib61","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1091\/mbc.e06-01-0008","article-title":"Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity","volume":"17","author":"Cabrero","year":"2006","journal-title":"Mol. Biol. Cell"},{"issue":"10","key":"10.1016\/j.biopha.2026.119652_bib62","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1128\/MCB.05155-11","article-title":"Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells","volume":"31","author":"de Zoeten","year":"2011","journal-title":"Mol. Cell Biol."},{"issue":"6489","key":"10.1016\/j.biopha.2026.119652_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat5314","article-title":"The integrated stress response: from mechanism to disease","volume":"368","author":"Costa-Mattioli","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biopha.2026.119652_bib64","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/jcp.23029","article-title":"Imatinib treatment inhibit IL-6, IL-8, NF-KB and AP-1 production and modulate intracellular calcium in CML patients","volume":"227","author":"Ciarcia","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119652_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110657","article-title":"TNF-alpha sculpts a maturation process in vivo by pruning tolerogenic dendritic cells","volume":"39","author":"Iberg","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119652_bib66","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1038\/s41598-019-42237-3","article-title":"Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells","volume":"9","author":"Knox","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:36:40Z","timestamp":1784529400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":66,"alternative-id":["S0753332226006888"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119652","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective HDAC6 inhibition perturbs autophagy and enhances integrated stress response-mediated immunogenic apoptosis in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119652"}}